Infectious Treatments
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
46
NCT02295813
Safety and Pharmacokinetics Study of FBF001
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2012
Completion: Not specified
NCT05279352
Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome
Phase: Phase 2
Start: Mar 21, 2022
Completion: Jul 15, 2022
Loading map...